SKI Market

A+| A| A-|

Indian Indices

Sensex

74,775.74 -1,092.06
( -1.44%)

Global Indices

Nasdaq

51,069.65 379.68
(0.75%)

Dow Jones

7,605.10 20.47
(0.27%)

Hang Seng

66,385.32 1,692.20
(2.62%)

Nikkei 225

10,420.12 -5.84
(-0.06%)

Forex

USD-INR

95.93 0.16
(0.16%)

EUR-INR

111.54 0.10
(0.09%)

GBP-INR

128.71 -0.01
(-0.01%)

JPY-INR

0.60 0.00
(0.17%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Fredun Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

539730

INE194R01017

514.6538079

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

41.43

1375.72

EPS(TTM)

Face Value()

Div & Yield %

60.24

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	453.82	348.16	274.68	224.46	133.89	112.77
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	453.82	348.16	274.68	224.46	133.89	112.77
Other Income	2.45	0.92	1.82	1.63	1.40	0.52
Stock Adjustments	-6.05	22.44	37.72	0.01	-1.17	5.04
Total Income	450.22	371.52	314.22	226.10	134.12	118.33
EXPENDITURE :
Raw Materials	321.89	282.42	245.57	176.45	100.60	86.12
Power & Fuel Cost	4.79	4.03	3.17	3.68	3.32	3.21
Employee Cost	22.23	12.50	11.54	10.66	8.66	8.95
Other Manufacturing Expenses	17.17	11.68	8.08	6.59	3.87	4.41
Selling & Administrative Expenses	26.42	20.77	14.55	12.76	7.80	6.43
Miscellaneous Expenses	2.63	1.22	1.71	0.46	0.28	0.37
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	395.12	332.61	284.62	210.60	124.54	109.48
Operating Profit	55.10	38.90	29.60	15.50	9.58	8.85
Interest	22.38	13.65	9.28	4.74	4.37	4.48
Gross Profit	32.72	25.25	20.32	10.76	5.21	4.37
Depreciation	4.45	3.80	2.81	2.16	2.00	1.88
Profit Before Tax	28.27	21.45	17.51	8.60	3.21	2.49
Tax	7.12	5.54	4.29	2.21	0.76	0.44
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.35	0.29	2.41	0.05	0.44	0.15
Reported Net Profit	20.81	15.62	10.81	6.34	2.01	1.90
Extraordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Net Profit	20.81	15.62	10.81	6.34	2.01	1.90
Adjustment below Net Profit	-0.34	-0.07	0.05	0.02	0.00	8.27
P & L Balance brought forward	43.77	28.55	18.00	11.93	10.18	0.00
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.33	0.33	0.31	0.28	0.27	0.00
P & L Balance carried down	63.91	43.77	28.55	18.00	11.93	10.18
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	7.00	7.00	7.00	7.00	7.00	6.60
Dividend Per Share(Rs)	0.70	0.70	0.70	0.70	0.70	0.66
Earnings Per Share-Unit Curr	44.07	33.25	23.84	14.29	5.05	4.77
Earnings Per Share(Adj)-Unit Curr	44.07	33.25	23.84	14.29	5.05	4.77
Book Value-Unit Curr	299.47	255.15	194.27	153.07	107.96	103.57
Book Value(Adj)-Unit Curr	299.47	255.15	194.27	153.07	107.96	103.57

74,775.74 -1,092.06 ( -1.44%)

51,069.65 379.68 (0.75%)

7,605.10 20.47 (0.27%)

66,385.32 1,692.20 (2.62%)

10,420.12 -5.84 (-0.06%)

95.93 0.16 (0.16%)

111.54 0.10 (0.09%)

128.71 -0.01 (-0.01%)

0.60 0.00 (0.17%)